Evidence map›Paper›PMID 12018913›Full record

ArticleDigestive diseases and sciences2002

Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro.

Jasleen Jasleen, Stanley W Ashley, Naoshi Shimoda, Michael J Zinner, Edward E Whang

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jasleen JasleenDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Stanley W Ashley
Naoshi Shimoda
Michael J Zinner
Edward E Whang
Brigham and Women's Hospital · USHarvard University · US

Funding

SURGERY AND INTESTINAL ADAPTATIONR01DK047326 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ASHLEY, STANLEY W · 1999 to 2005
$983k
CELL CYCLE REGULATION IN INTESTINAL REGENERATIONK08DK002786 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI WHANG, EDWARD E · 2000 to 2004
$660k
SURGERY AND INTESTINAL ADAPTATIONR29DK047326 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ASHLEY, STANLEY W · 1994 to 1998
–
NIDDK NIH HHS DK02786NIDDK NIH HHS DK47326
6 · The paper itself

Abstract

Glucagon-like peptide 2 (GLP-2) is a potent intestine-specific growth factor. To determine whether GLP-2 has a direct effect on cellular proliferation, we examined the effects of GLP-2 on three different intestinal epithelial cell lines: Caco-2, T84, and IEC-6. Proliferation was assessed by measuring [3H]thymidine incorporation into cellular DNA. The expression of the cell cycle regulators cyclins D1, E, and A was determined by western blotting. GLP-2 stimulated [3H]thymidine incorporation in Caco-2 and T84 cells but not in IEC-6 cells. In Caco-2 cells, increased [3H]thymidine incorporation was detectable by day 1 and was maximal at day 5 following initiation of daily GLP-2 administration. Increased [3H]thymidine incorporation persisted for three days following treatment with a single dose of GLP-2. GLP-2 administration resulted in the induction of cyclins D1, E, and A in Caco-2 cells. These results suggest that GLP-2 acts directly on human intestinal epithelial cells to stimulate their proliferation.

Indexed as

Cell DivisionCell LineDNAEpithelial CellsGlucagon-Like Peptide 2Glucagon-Like PeptidesIntestinal MucosaPeptidesThymidineTritiumDNAGlucagon-Like Peptide 2Glucagon-Like PeptidesPeptidesThymidineTritium

Identifiers

PMID12018913
OpenAlexW164167043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.